Fedenia Advisers’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-473
Closed -$45.4K – 293
2026
Q2
$45.4K Buy
+473
New +$48.5K 0.01% 224
2025
Q1
– Sell
-473
Closed -$43.6K – 286
2024
Q4
$43.6K Buy
+473
New +$45.5K 0.03% 261

Other funds holding LMAT

Fedenia Advisers's LMAT Position: Q3 2026 in Review

Fedenia Advisers sold out of LeMaitre Vascular (LMAT) in Q3 2026, closing a stake of 473 shares — an estimated $45.4K sold.

Fedenia Advisers first reported a position in LMAT in Q4 2024 and held it in 2 quarters. The position peaked at $45.4K in Q2 2026. 164 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.

  • Fedenia Advisers reported no remaining LeMaitre Vascular position as of Q3 2026 after selling out during the quarter.
  • Fedenia Advisers sold 473 LeMaitre Vascular shares in Q3 2026, an estimated $45.4K.
  • Fedenia Advisers first reported a position in LeMaitre Vascular in Q4 2024 and held it in 2 quarters.
  • Fedenia Advisers's LeMaitre Vascular position peaked at $45.4K in Q2 2026.
  • 164 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.

Based on Fedenia Advisers's 13F filing for Q3 2026, filed 22 Oct 2026.